The Week

Aehr Test closed the week at $86.26, up 6.74%, while the S&P 500 added just 0.09%, leaving the stock ahead of the benchmark by roughly 6.65 percentage points. The week unfolded in a pullback-then-rally pattern. Shares opened Monday at $81.30, slid to an intraday low of $74.23 on Tuesday, and then climbed steadily from Wednesday. Friday brought the strongest session, with the price touching $86.67, near the week’s high. Amplitude was 15.3%, and daily volume ran about 50% above the 60-day median for the stock. Trading activity was clearly elevated.

Key Events

The company’s own calendar was light, with one notable item. On Friday 4 September, Aehr Test said its CEO and CFO will meet investors at the Lake Street Best Ideas Growth Conference. That was the only direct corporate engagement disclosed during the week. In the same session, the stock jumped as much as 10.59% intraday and landed on the day’s list of top US gainers. Commentary linked the move to renewed confidence around AI demand, while also flagging equity dilution as a lingering concern among some market participants. Earlier in the week, an industry piece on computing demand behind precision medicine placed Aehr among companies being discussed. Overall, the week was driven more by a shift in sentiment than by a single release.

Analyst Ratings

Coverage remains small but uniformly constructive. Five brokers rate the stock, all at buy; there are no hold, underweight or sell ratings. The consensus rating is strong buy, with a consensus target of $130, about 50.71% above the latest close of $86.26. Targets range from $110 to $175, a wide spread that shows real disagreement on the upside. Within its semiconductor materials and equipment industry, Aehr ranks 22nd out of 31 names, placing it in the lower-middle band among rated peers.

The Week Ahead

The macro calendar is fairly heavy. On Tuesday 8 September, the US releases the NFIB small business optimism index, with a prior reading of 99.8. Thursday 10 September brings initial jobless claims, final demand PPI, PPI excluding food and energy, existing home sales and wholesale sales. A 10-year Treasury auction is scheduled the same day, with prior high yield of 4.683% and a bid-to-cover ratio of 2.53, a useful read on rate expectations. Aehr has no earnings date on the calendar. For this stock, the key question is whether the AI-related capital-expenditure narrative holds and whether elevated trading volume can persist.

In Short

Aehr Test finished the week with a late burst of strength, closing near the top of its range and beating the broad market by a wide margin. The analyst picture leans constructive, with a strong-buy consensus and a target well above spot, though the wide target band reflects genuine dispersion. The latest daily flow snapshot shows large-lot money tilting to the buy side, but the dilution debate continues to sit in the background. The next stretch depends on whether AI demand stays front and centre for investors, and whether this week’s macro prints shift the rate outlook.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.